D
Portage Biotech Inc. PRTG
$5.42 -$0.54-9.06% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Net Income 92.46% 95.24% 73.63% 72.02% 73.65%
Total Depreciation and Amortization -23.08% -33.33% -53.33% -27.27% --
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -98.08% -98.83% -1,416.67% -155.73% -75.80%
Change in Net Operating Assets 206.39% 257.08% -113.54% 48.92% 77.74%
Cash from Operations 64.50% 67.71% 63.65% 51.17% 33.33%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -16.67% -27.27% 0.00% -28.57% --
Issuance of Common Stock -- -79.86% -100.00% -99.84% -100.00%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- 112.12%
Cash from Financing 26,625.00% -80.08% -125.64% -101.32% -100.19%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 84.98% -102.48% 63.08% 40.50% 87.77%